Tensec | $12,000,000 | (Jun 19, 2025)
Grifin | $11,000,000 | (Jun 19, 2025)
Materna Medical | $20,000,000 | (Jun 19, 2025)
Certified by Founder
Lodge
Carmot Therapeutics, Inc.
start up
United States
- Berkeley
- 26/07/2022
- Series D
- $160,000,000
Carmot Therapeutics, Inc. is a clinical-stage company dedicated to the discovery and development of innovative medicines. Carmot applies a transformative, patented drug discovery approach, Chemotype Evolution to explore novel frontiers of chemistry and biology. Using Chemotype Evolution, Carmot has developed a portfolio of drug candidates in metabolic disease and oncology.
- Industry Biotechnology Research
- Website https://carmot-therapeutics.us/contact-us/
- LinkedIn https://www.linkedin.com/company/carmot-therapeutics-inc/
NaroIQ | $6,500,000 | (Jun 19, 2025)
Polar | $9,860,072 | (Jun 19, 2025)
Darwix AI | $1,500,000 | (Jun 19, 2025)
Infinity Bio, Inc. | $8,000,000 | (Jun 19, 2025)
HydroBlok | $6,000,000 | (Jun 19, 2025)
Orange Quantum Systems | $13,742,820 | (Jun 19, 2025)
Corvia Medical, Inc. | $55,000,000 | (Jun 18, 2025)
GetZoot | $6,000,000 | (Jun 18, 2025)
AthenaHQ | $2,200,000 | (Jun 18, 2025)